COMPONENTS FOR MEDICAL CIRCUITS

(19)

(11)

EP 2 515 980 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	19.05.2021 Bulletin 2021/20

(45)	Mention of the grant of the patent:
	07.04.2021 Bulletin 2021/14

(21)	Application number: 10838780.4

(22)	Date of filing: 22.12.2010

(51)

International Patent Classification (IPC):

A61M 16/00^(2006.01)
A61M 39/00^(2006.01)
B32B 3/30^(2006.01)
B32B 3/28^(2006.01)
B32B 27/00^(2006.01)
A61M 16/01^(2006.01)
A61M 16/08^(2006.01)
A61M 16/16^(2006.01)

A61M 13/00^(2006.01)
B32B 3/26^(2006.01)
B32B 5/22^(2006.01)
B32B 5/18^(2006.01)
A62B 7/00^(2006.01)
A61M 16/06^(2006.01)
A61M 16/10^(2006.01)

(86)	International application number:
	PCT/IB2010/003454

(87)	International publication number:
	WO 2011/077250 (30.06.2011 Gazette 2011/26)

(54)	COMPONENTS FOR MEDICAL CIRCUITS BESTANDTEILE FÜR MEDIZINISCHE SCHALTKREISE ÉLÉMENTS POUR CIRCUITS MÉDICAUX

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

22.12.2009 US 289089 P

(43)	Date of publication of application:
	31.10.2012 Bulletin 2012/44

(60)	Divisional application:
	21160568.8

(73)	Proprietor: Fisher & Paykel Healthcare Limited
	East Tamaki, Auckland 2013 (NZ)

(72)	Inventors:
	HERMEZ, Laith, Adeeb St Heliers Auckland 1071 (NZ) ORCHARD, Kieran, Michael Hawera, 4671 (NZ) GIERKE, Timothy, Dee Wilmington, Delaware 19810 (US)

(74)	Representative: Mewburn Ellis LLP
	Aurora Building Counterslip Bristol BS1 6BX Bristol BS1 6BX (GB)

(56)

References cited: :

EP-A1- 1 516 643
EP-B1- 0 521 726
US-A1- 2003 207 640
US-A1- 2009 020 124
US-B2- 7 140 366

EP-A2- 1 166 814
WO-A1-2009/012049
US-A1- 2004 099 268
US-B1- 6 203 534

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).